Sustainability & Climate

TPG RE Finance Trust declared a steady $0.24 dividend. We analyze if this signals portfolio resilience or a strategic play in a volatile market.

Your health plan is evolving beyond medical bills. Insurers are now funding doulas, food, and transport to tackle the root causes of poor health.

Updated trial results for Lilly's Inluriyo-Verzenio combo extend life without chemo, positioning the firm for dominance in a competitive oncology market.

Global crypto exchange HTX gains a crucial regulatory nod in Pakistan, paving the way for licensed operations in one of the world's fastest-growing digital asset hubs.

A novel drug for alcohol use disorder gets key scientific backing. It promises the benefits of psychedelics with fewer risks, shaking up a $35B market.

Sintana Energy's all-share acquisition of Challenger gets final approval, creating a new exploration leader with high-impact assets in Namibia and Uruguay.

Aligos Therapeutics is using strategic stock grants to lure top talent. Is this a savvy growth play or a creeping cost for shareholders? We break it down.

Serve Robotics just deployed the largest U.S. sidewalk delivery fleet. We dive into the tech, the competition, and the high-stakes economics of this silent revolution.

A hybrid law firm just won a top ABA award by building a tech platform to help disabled Americans navigate bureaucracy. Is this the future of legal access?

Long Beach's new Black-Serving Institution status isn't just an equity win; it's a strategic investment in the diverse STEM talent America's defense sector needs.

An independent study shows Mesoblast’s cell therapy has superior remission rates over a market leader, hinting at a new standard of care and a big win for investors.

With a $2.5B boost from Blue Owl, Finance of America aims to move beyond reverse mortgages and reshape how millions of retirees access their home equity.

As John Lindsay retires, H&P anoints tech-savvy insider Trey Adams. A look at how this smooth transition secures a legacy of innovation.

New journalism awards tackle AI's risks and Indigenous health gaps, revealing how media innovation aims to build a healthier, more equitable Canada.

Nusano won a "Best Company" award, but the real story is how its culture is a strategic asset powering its mission to disrupt the critical isotope market.

First Trust unveils its new Dividend Aristocrats Target Income ETF in Europe, blending stable dividend stocks with a covered call strategy for yield-seekers.

A top advisor's move to independence reveals a major shift in how ultra-high-net-worth families are securing multi-generational wealth and resilience.

A funding round reveals a deeper strategy to tackle the healthcare labor crisis and soaring Medicaid costs with tech, data, and a focus on human dignity.

An Atlanta initiative is scaling a proven model to close the 'word gap.' It's not just about equity; it's a long-term investment in our future economy.

Beyond logistics, new AI-powered systems are redefining trust and efficiency in drug development. See how one company is setting a new human-centered standard.